Vestmark Advisory Solutions’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $770K | Sell |
8,824
-6,348
| -42% | -$554K | 0.01% | 542 |
|
|
2025
Q1 | $1.04M | Buy |
15,172
+11,943
| +370% | +$816K | 0.03% | 386 |
|
|
2024
Q4 | $251K | Sell |
3,229
-2,867
| -47% | -$223K | 0.01% | 527 |
|
|
2024
Q3 | $409K | Sell |
6,096
-27,040
| -82% | -$1.81M | 0.02% | 407 |
|
|
2024
Q2 | $3.76M | Buy |
33,136
+202
| +0.6% | +$22.9K | 0.16% | 145 |
|
|
2024
Q1 | $4.57M | Sell |
32,934
-3,110
| -9% | -$431K | 0.2% | 125 |
|
|
2023
Q4 | $4.47M | Buy |
36,044
+30,541
| +555% | +$3.79M | 0.23% | 109 |
|
|
2023
Q3 | $513K | Sell |
5,503
-3,237
| -37% | -$302K | 0.04% | 291 |
|
|
2023
Q2 | $1.12M | Buy |
8,740
+390
| +5% | +$50.1K | 0.04% | 425 |
|
|
2023
Q1 | $970K | Sell |
8,350
-494
| -6% | -$57.4K | 0.04% | 444 |
|
|
2022
Q4 | $1M | Buy |
8,844
+2,392
| +37% | +$271K | 0.05% | 411 |
|
|
2022
Q3 | $520K | Sell |
6,452
-13,110
| -67% | -$1.06M | 0.03% | 527 |
|
|
2022
Q2 | $1.46M | Buy |
19,562
+3,738
| +24% | +$279K | 0.08% | 296 |
|
|
2022
Q1 | $2.02M | Buy |
15,824
+4,492
| +40% | +$574K | 0.11% | 233 |
|
|
2021
Q4 | $1.52M | Buy |
11,332
+644
| +6% | +$86.4K | 0.09% | 290 |
|
|
2021
Q3 | $1.46M | Buy |
10,688
+2,008
| +23% | +$275K | 0.1% | 264 |
|
|
2021
Q2 | $927K | Buy |
8,680
+4,408
| +103% | +$471K | 0.07% | 336 |
|
|
2021
Q1 | $384K | Buy |
+4,272
| New | +$384K | 0.03% | 526 |
|